Debing Shi

1.5k total citations · 1 hit paper
31 papers, 1.0k citations indexed

About

Debing Shi is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Debing Shi has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Debing Shi's work include Colorectal Cancer Surgical Treatments (11 papers), Colorectal Cancer Screening and Detection (8 papers) and Colorectal and Anal Carcinomas (8 papers). Debing Shi is often cited by papers focused on Colorectal Cancer Surgical Treatments (11 papers), Colorectal Cancer Screening and Detection (8 papers) and Colorectal and Anal Carcinomas (8 papers). Debing Shi collaborates with scholars based in China, United States and Australia. Debing Shi's co-authors include Xinxiang Li, Sanjun Cai, Yongzhi Yang, Cheng Kong, Yanlei Ma, Jianqiang Liu, Lutao Du, Ye Xu, Junjie Peng and Weiguo Fu and has published in prestigious journals such as Nature Communications, PLoS ONE and Oncogene.

In The Last Decade

Debing Shi

31 papers receiving 1.0k citations

Hit Papers

Integrated metagenomic and metabolomic analysis reveals d... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debing Shi China 16 482 418 243 235 130 31 1.0k
Xianghui He China 18 277 0.6× 279 0.7× 118 0.5× 159 0.7× 88 0.7× 90 951
Jae Yoon Jung South Korea 22 561 1.2× 230 0.6× 147 0.6× 145 0.6× 96 0.7× 47 1.7k
Joanna Ilvesaro Finland 18 467 1.0× 261 0.6× 201 0.8× 98 0.4× 127 1.0× 26 1.2k
Guang‐Ying Dong China 15 468 1.0× 143 0.3× 179 0.7× 130 0.6× 55 0.4× 23 1.3k
Marie Moreau France 18 298 0.6× 252 0.6× 77 0.3× 213 0.9× 120 0.9× 32 986
Reynold I. Lopez‐Soler United States 17 427 0.9× 174 0.4× 75 0.3× 253 1.1× 91 0.7× 41 1.0k
Roman C. Brands Germany 16 212 0.4× 236 0.6× 108 0.4× 149 0.6× 96 0.7× 58 729
Andrea Tandara Germany 14 266 0.6× 135 0.3× 102 0.4× 397 1.7× 89 0.7× 23 1.3k
Ramon Lopez Perez Germany 20 530 1.1× 265 0.6× 89 0.4× 135 0.6× 244 1.9× 41 1.2k
Yi An United States 15 165 0.3× 216 0.5× 74 0.3× 246 1.0× 165 1.3× 47 778

Countries citing papers authored by Debing Shi

Since Specialization
Citations

This map shows the geographic impact of Debing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debing Shi more than expected).

Fields of papers citing papers by Debing Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debing Shi. The network helps show where Debing Shi may publish in the future.

Co-authorship network of co-authors of Debing Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Debing Shi. A scholar is included among the top collaborators of Debing Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debing Shi. Debing Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yongzhi, Yangyang Guo, Yan Ding, et al.. (2025). Perioperative administration of CBM588 in colorectal cancer radical surgery: A single-center, randomized controlled trial. Cell Reports Medicine. 6(7). 102234–102234. 1 indexed citations
2.
Kong, Cheng, Jinming Li, Guang Liu, et al.. (2024). Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. Microbiome. 12(1). 274–274. 5 indexed citations
3.
Yu, Shaojun, Weixing Dai, Senlin Zhao, et al.. (2023). Function and mechanism of MCM8 in the development and progression of colorectal cancer. Journal of Translational Medicine. 21(1). 623–623. 6 indexed citations
5.
Yang, Xiaohong, Chuansen Zhang, Wei Wang, et al.. (2023). CNN2 silencing inhibits colorectal cancer development through promoting ubiquitination of EGR1. Life Science Alliance. 6(7). e202201639–e202201639. 3 indexed citations
6.
Kong, Cheng, Lei Liang, Guang Liu, et al.. (2022). Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer. Gut. 72(6). 1129–1142. 154 indexed citations breakdown →
7.
He, Xuefeng, Huaijun Chen, Xinyang Zhong, et al.. (2022). BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer. International Journal of Biological Sciences. 19(1). 331–345. 33 indexed citations
8.
Zhao, Senlin, Bingjie Guan, Yushuai Mi, et al.. (2021). LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene. 40(28). 4709–4724. 70 indexed citations
9.
Yang, Yongzhi, Lutao Du, Debing Shi, et al.. (2021). Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nature Communications. 12(1). 6757–6757. 162 indexed citations
10.
Shen, Lijun, Miao Mo, Huixun Jia, et al.. (2018). Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China. Cancer Management and Research. Volume 10. 653–661. 8 indexed citations
11.
Shi, Debing, Lei Liang, Hongtu Zheng, et al.. (2016). Silencing of long non-coding RNA SBDSP1 suppresses tumor growth and invasion in colorectal cancer. Biomedicine & Pharmacotherapy. 85. 355–361. 13 indexed citations
12.
Zhuo, Changhua, et al.. (2014). Histological characteristics of collagen denaturation and injuries in bipolar radiofrequency-induced colonic anastomoses. Pathology - Research and Practice. 211(3). 214–218. 15 indexed citations
13.
Wang, Yuwei, Changhua Zhuo, Debing Shi, et al.. (2014). Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study. International Journal of Colorectal Disease. 30(1). 131–137. 20 indexed citations
14.
Zhu, Ji, Fangqi Liu, Peng Lian, et al.. (2014). Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study. Radiation Oncology. 9(1). 70–70. 51 indexed citations
15.
Shi, Debing, Hongtu Zheng, Changhua Zhuo, et al.. (2014). Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer. Medical Oncology. 31(7). 31–31. 71 indexed citations
16.
Peng, Junjie, Ying Ding, Debing Shi, et al.. (2014). Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers. PLoS ONE. 9(8). e106344–e106344. 34 indexed citations
17.
Peng, Junjie, Xinxiang Li, Ying Ding, et al.. (2013). Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?. Radiation Oncology. 8(1). 290–290. 2 indexed citations
18.
Wei, Ping, Nu Zhang, Ye Xu, et al.. (2013). TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer. Journal of Translational Medicine. 11(1). 313–313. 84 indexed citations
19.
Peng, Junjie, Debing Shi, Karyn A. Goodman, et al.. (2011). Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29. Radiation Oncology. 6(1). 93–93. 38 indexed citations
20.
Gui-bo, Yin, et al.. (2009). Study of the electrospun PLA/silk fibroin‐gelatin composite nanofibrous scaffold for tissue engineering. Journal of Biomedical Materials Research Part A. 93A(1). 158–163. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026